G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...

For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...

GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...

If you’ve been paying attention to the weight loss world, you’ve probably heard about GLP-1 receptor agonists like Ozempic, ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

The rise of GLP-1s (glucagon-like peptides) has revolutionized obesity management. These medications help people shed pounds ...

For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced ...

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

A Columbia University dermatologist argues that physicians in her specialty should be on the lookout for metabolic syndrome ...

The study included patients with T2D prescribed a GLP-1 RA, insulin, or metformin between April 30, 2005, and October 31, 2023 (51,617; 611,115; and 938,602 patients, respectively). Groups were ...